Every GenAI initiative starts with the same three options on a whiteboard. Build in-house and own everything. Buy something off the shelf and move fast. Bring in a partner and split the difference.
The whiteboard version compares license fees to salaries. The real version compares something else: the probability of ever reaching production, and what each path costs when it does not.
MIT's Project NANDA found that 95% of GenAI initiatives deliver zero measurable ROI. That number is not evenly distributed across the three paths. Industry analyses consistently find vendor-led AI projects succeeding at roughly twice the rate of pure internal builds. The decision is not primarily about cost. It is about which failure modes you are signing up for.
What building in-house actually costs
The salary math alone is sobering. The average US machine learning engineer earns around $183,000. GenAI and LLM specialization carries a 40 to 60% premium. MLOps expertise, the skill that actually gets systems into production, adds another 25 to 40%. A credible minimum team is four to six people: an ML lead, two engineers, an MLOps engineer, and a product-side owner.
Realistic year-one estimates land between $1.5M and $2.5M once salaries, benefits, cloud compute, tooling licenses, and management overhead are counted. The costs people forget are the ones that hurt: compute bills of $8 to $15K per month before a single customer-facing feature ships, enterprise tooling at $30 to $60K per year, and attrition. Senior ML engineers average under two years at non-tech companies, and replacing one costs 50 to 75% of their annual salary.
None of that is the real risk. The real risk is time. The industry average from POC/V to production is nine months or more, and an in-house team discovers the four root causes of GenAI failure, unclear value, unvalidated data, missing production engineering, no operational model, sequentially, on your payroll, at the most expensive possible moment to fix each one.
Building makes sense in one specific situation: AI is your product, and owning the capability is the competitive moat itself. For everyone else, it is the most expensive way to learn lessons a partner has already learned.
What buying off the shelf actually gets you
Off-the-shelf GenAI tools are the fastest path to something. They are rarely the path to the thing you scoped.
The pattern repeats: the tool covers 70% of the requirement, the remaining 30% is the part that made the project worth doing, and the workarounds begin. Your data does not fit the connector. Your compliance team needs audit capabilities the vendor roadmap does not include. Your costs scale per-seat or per-query in ways that punish exactly the adoption you are trying to drive.
Buying is the right answer for commodity capabilities: systems of record, horizontal copilots, compliance-heavy platforms where you are paying for a decade of someone else's edge cases. It is the wrong answer for the differentiating layer: the workflows, decisions, and customer experiences specific to your business. Differentiating capability built on someone else's roadmap is not differentiating for long.
What a partner changes and what it does not
A traditional consulting engagement solves the staffing problem and often recreates every other one. Bespoke builds from scratch, timelines that vary with the team assigned, production engineering treated as a phase after the pilot, and a handover that leaves your team operating a system they did not build and do not fully understand.
The variable that separates outcomes is not whether you use a partner. It is whether the partner runs a repeatable production process or starts from a blank page. Five questions expose the difference:
- Do they show you a working system before custom development begins, or a slide deck?
- Do they validate on your real data before you commit, or after?
- Is production engineering, observability, security, governance, cost control, reliability, in the architecture from day one, or a hardening phase at the end?
- Who operates the system after launch, and is improvement continuous or contractual?
- Does your team inherit something they can understand and extend, or a black box?
A partner with real answers to those five questions compresses the nine-month industry timeline because they are not rediscovering the failure modes on your budget. They eliminated them structurally, on previous engagements.
The honest comparison
Most organizations land on a portfolio: buy the commodity, partner for the differentiating systems, and grow internal ownership as those systems prove out. The expensive mistake is using the build path to learn what the failure modes are.
How Inferdat fits
ProdWorks™ is a four-stage delivery process built to answer those five questions directly. SHOW puts a working system in front of stakeholders before custom code. PROVE validates on your real data, in your environment, free, and you keep what gets built. BUILD deploys production-grade from the first line of code, with all five operational layers encoded in the architecture rather than retrofitted. OPERATE keeps the system improving after launch.
The result is partner economics without the consulting failure modes: six to ten weeks to production at a fixed price, against an industry average of nine months, and a system your team can actually operate.
Frequently asked questions
Should we build our GenAI application in-house or buy?
Build in-house only if AI is your core product and owning the capability is itself the moat. Buy for commodity capabilities where vendors have already absorbed the edge cases. For differentiating workflows specific to your business, a process-driven partner typically reaches production faster and at lower total cost than either.
How much does it cost to build an in-house AI team?
Realistic year-one estimates run $1.5M to $2.5M for a full team including salaries, benefits, compute, tooling, and management. US ML engineers average around $183K, with 40 to 60% premiums for GenAI specialization. Attrition adds hidden cost: senior ML engineers average under two years of tenure at non-tech companies.
Why do internal AI builds fail more often than vendor-led projects?
Internal teams encounter the root causes of GenAI failure, unclear value, unvalidated data, missing production engineering, no operational model, sequentially and mid-project, when fixes are most expensive. Experienced partners have eliminated these structurally across prior engagements. Industry analyses put vendor-led success rates at roughly double pure internal builds.
What should I ask an AI implementation partner before signing?
Five questions: Do we see a working system before custom development? Is validation on our real data before commitment? Is production engineering in the day-one architecture? Who operates and improves the system post-launch? Does our team inherit something we can understand and extend?
What does "production-grade" mean in a GenAI engagement?
Five operational layers present from day one: observability, security, governance, cost control, and reliability. If these are a hardening phase after the pilot, the pilot is getting rebuilt.
How fast can GenAI realistically reach production with a partner?
The industry average from POC/V to production is nine months or more. A partner running a repeatable process with pre-built production infrastructure, like ProdWorks™, delivers in six to ten weeks, because the production layers are reused architecture rather than rebuilt per engagement.
ProdWorks™ delivers production-grade GenAI in six to ten weeks at a fixed price, starting with a working demo before any custom code, and a free PROVE stage on your own data. Talk to our team.